Trial Profile
Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 08 Sep 2009
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Sulfasalazine
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Wyeth
- 01 Jul 2009 Results have been reported in the Annals of the Rheumatic Diseases.
- 11 Dec 2006 New trial record.